The leadership team at EpimAb Biotherapeutics has experience in the therapeutics and pharmaceutical industry. The team members have a biochemistry degree from the University of Illinois Urbana-Champaign and a pharmaceutical sciences degree from the University of Michigan. The team members have experience working as an analyst at Passaic Capital, Thirty30 Capital, Jefferies & Company, and Wells Fargo Securities.
View all